TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Length of stent patency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: engagement in self-help activities
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: intention to use campus resources
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: change in anxiety severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decreases in nighttime fears
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: increases in number of nights slept in own bed
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: CSRT improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PPA composite scores improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dual-task ability improvement (timed up and go test)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PAC-SYM scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: day-28 PCR-adjusted treatment failures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: state-anxiety score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Barrier breakdown
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Perforation and porosity alarms
Endpoint domain: Adverse events/effects
Primary endpoint: Interval from intervention to delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intervention to hospital discharge duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: seizure-free rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: time to discontinuation (retention rate)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Reduction in primary endpoint with invasive vs conservative strategy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: E2-oocyte ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of sore arm
Endpoint domain: Adverse events/effects
Primary endpoint: rate of nausea
Endpoint domain: Adverse events/effects
Primary endpoint: Postoperative increase in serum levels of CK‐MB and cTnI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Response rate to postal self-completed questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Forced expiratory flow rate between 25% and 75% of vital capacity (FEF25‐75)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Morning peak flow rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: VAS pain scores in the first 24 hours post-operatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: use of morphine in the PCA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SPID24hr scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postoperative vomiting
Endpoint domain: Adverse events/effects
Primary endpoint: Staff's perception of skill
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Confidence in key elements of enhanced relapse prevention
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Competence rating in relapse prevention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to request analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Travel costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Rate of recorded tetanus vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum concentrations of 25(OH)D₃
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in symptomatic grade 3/4 mucositis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change or positive gain in body weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HDSS scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of patients requiring procedure repetition
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: suture application time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Sodium intake reduction (mg/day)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion meeting sodium intake recommendation (1500 mg/day)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean Knee Society scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in ROM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wound healing problems and infections
Endpoint domain: Adverse events/effects
Primary endpoint: Central Corneal Thickness (CCT) measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of high-risk HPV types
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: serum epinephrine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Histological recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Unified Dyskinesia Rating Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urinary and serum phenolic acids concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mayo score reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Speech improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physiological breathing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative fistula occurrence
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement in treatment group
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mortality rate in HIV-positive individuals
Endpoint domain: Mortality/survival
Primary endpoint: respiratory failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: death within 31 days
Endpoint domain: Mortality/survival
Primary endpoint: death within 84 days
Endpoint domain: Mortality/survival
Primary endpoint: incidence of infections longer than 14 days after transplantation
Endpoint domain: Adverse events/effects
Primary endpoint: Bone progression-free survival (BPFS)
Endpoint domain: Mortality/survival
Primary endpoint: Reduction of co-morbid depression and anxiety
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Epidural catheter dislodgment rate
Endpoint domain: Adverse events/effects
Primary endpoint: Total cost for epidural analgesia
Endpoint domain: Resource use
Primary endpoint: mean fluorescence intensity of donor-specific antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Time to complete ADLs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in inflamed lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: mammography use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: At-home daily consumption of vegetables
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Use of low-fat/fat-free milk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of child-initiated vegetable snacking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of large PA shifts (>5 mm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average isocentre shifts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: anti-HR-HPV antibody titres
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean peri-implant marginal bone levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aesthetic outcome score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Frequency of thromboembolic complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ongoing pregnancy rate per initiated cycle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Proportion of appropriate ovarian responses (5-14 oocytes)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Need for dose adjustments during controlled ovarian stimulation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: mechanical failure rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: curative effect of acupuncture on dementia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: First-attempt success rate for vascular access
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to initial success for vascular access
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: composite of fatal and non-fatal coronary events
Endpoint domain: Mortality/survival
Primary endpoint: Mean T scores at 6-9 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of adherent patients
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Absolute variation of MARS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absolute variation of DAI scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean of decayed, missing, and filled surfaces
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum MDA content
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Ratio of SOD/MDA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Local and regional control
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of acute adverse effects of grade 3 or greater
Endpoint domain: Adverse events/effects
Primary endpoint: Number of correct diagnoses of Fallopian tube patency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: health-related outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean maximum knee flexion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of extension lag
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative bioavailability of intranasal to intramuscular naloxone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pupillometry difference in antagonism
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total AGE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: MDA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean PPD decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of detection of P. gingivalis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Spontaneous defibrillation after reperfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Lactate extraction rate at 60 minutes of reperfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Postreperfusion values of cardiac troponin T
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: mean training time to achieve correct administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: preference for dulaglutide SUP over FlexTouch®
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: oxygen consumption at the lactate threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: maximum oxygen consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: mean IOP at 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Major adverse clinical event rates
Endpoint domain: Adverse events/effects
Primary endpoint: Total respiratory system resistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Total time for the colonoscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rumination levels
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: time from injury to complete débridement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: area of burns excised
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: increased body mass index (BMI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: increased arm muscle area and circumference
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: absence of triggering
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: General activity levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Greater visceral fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Higher serum lipids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Normalized stance and double support of the paretic limb
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ankle dorsiflexion during swing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Normalized initial loading response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in procedural skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC of 1-PP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Elimination half-life of 1-PP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment-related grade 3 to 4 toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Sexual dysfunction scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Performance on Trails B
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: awakening cortisol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Percentage of participants decreasing alcohol consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adiponectin concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Frequency and duration of pain reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change from baseline in ZAN-BPD total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response rates (≥ 50% decrease in ZAN-BPD total score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean weight change from baseline to endpoint
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Duration of operating time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Lymph nodes harvesting
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: occurrence of cough, bronchospasm and stridor
Endpoint domain: Adverse events/effects
Primary endpoint: Median duration of stent patency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: discharge home
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Adherence to colorectal cancer surveillance guidelines for colonoscopy
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Concentration of TNF-alpha in blood serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Apoptosis rate of bone marrow CD34+ cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: rate of perforation
Endpoint domain: Adverse events/effects
Primary endpoint: rate of correct words read per minute
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incision pain at rest and on swallowing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: opioid and nonopioid requirement
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Bifidobacterial levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximum peak systolic velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: resistivity index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: pulsatility index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Pain caused by DJ removal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time for DJ removal
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: exudate removal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FEV1 AUC0-24
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: FEV1 AUC12-24
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: E-RS total scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Emerging or worsening tremor
Endpoint domain: Adverse events/effects
Primary endpoint: Memory impairments
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Rate of deteriorating to chronic severe hepatitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mortality rate in patients with chronic severe hepatitis
Endpoint domain: Mortality/survival
Primary endpoint: PANSS-total score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PANSS-positive score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Life Scale improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Serum MMP-3 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum MIA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite of in‐hospital death, myocardial infarction, recurrent ischemia and repeat revascularization
Endpoint domain: Mortality/survival
Primary endpoint: Length of stay post‐PCI
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Mean area under the plasma concentration-time curve (AUC) of omeprazole
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: resting HR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Screening for sleep-disordered breathing (SDB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Duration of supplemental oxygen exposure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete protection from acute vomiting
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Complete protection from acute nausea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Hospitalizations per patient-year
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Patient and technique survival
Endpoint domain: Mortality/survival
Primary endpoint: 24-month LARC continuation probability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24-month cumulative unintended pregnancy probabilities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LARC satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reduction in Type 1 MI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction in larger spontaneous MIs (Type 1, ≥10× upper reference limit)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction in fatal MI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: One-Minute score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in retinal edema
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes